Option Care Health (NASDAQ:OPCH) Trading 4.5% Higher – Should You Buy?

Posted by Francis Steltz on Sep 16th, 2026

Option Care Health, Inc. (NASDAQ:OPCH – Get Free Report) shares rose 4.5% during trading on Wednesday . The company traded as high as $24.88 and last traded at $24.58. 2,180,041 shares traded hands during trading, a decline of 11% from the average session volume of 2,449,761 shares. The stock had previously closed at $23.52.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on OPCH shares. The Goldman Sachs Group began coverage on Option Care Health in a research report on Monday, June 8th. They set a “neutral” rating and a $22.00 target price on the stock. Stephens reaffirmed an “equal weight” rating and issued a $24.00 price target (down from $30.00) on shares of Option Care Health in a report on Friday, July 17th. Zacks Research upgraded Option Care Health from a “strong sell” rating to a “hold” rating in a research report on Monday, July 6th. Wall Street Zen raised Option Care Health from a “hold” rating to a “buy” rating in a report on Saturday, August 1st. Finally, Deutsche Bank Aktiengesellschaft restated a “hold” rating and set a $24.00 price objective (down from $26.00) on shares of Option Care Health in a research report on Thursday, July 30th. Seven research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $29.92.

Read Our Latest Stock Report on OPCH

Option Care Health Stock Performance

The firm has a market capitalization of $3.67 billion, a price-to-earnings ratio of 18.40, a price-to-earnings-growth ratio of 1.39 and a beta of 0.61. The firm’s 50-day moving average price is $23.12 and its two-hundred day moving average price is $24.23. The company has a debt-to-equity ratio of 0.91, a quick ratio of 0.98 and a current ratio of 1.47.

Option Care Health (NASDAQ:OPCH – Get Free Report) last posted its quarterly earnings results on Wednesday, July 29th. The company reported $0.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.43 by $0.02. The firm had revenue of $1.44 billion during the quarter, compared to analyst estimates of $1.42 billion. Option Care Health had a net margin of 3.68% and a return on equity of 18.74%. The company’s quarterly revenue was up 1.9% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.41 earnings per share. Option Care Health has set its FY 2026 guidance at 1.850-1.920 EPS. Sell-side analysts predict that Option Care Health, Inc. will post 1.69 earnings per share for the current year.

Institutional Trading of Option Care Health

Several institutional investors have recently bought and sold shares of OPCH. Sumitomo Mitsui Trust Group Inc. bought a new position in Option Care Health in the 1st quarter worth approximately $70,287,000. Norges Bank bought a new position in Option Care Health in the 4th quarter valued at $61,787,000. Van Berkom & Associates Inc. bought a new position in Option Care Health in the 1st quarter valued at $42,739,000. Bank of New York Mellon Corp acquired a new stake in shares of Option Care Health in the 2nd quarter valued at $19,600,000. Finally, Southpoint Capital Advisors LP increased its stake in shares of Option Care Health by 20.0% in the 1st quarter. Southpoint Capital Advisors LP now owns 3,600,000 shares of the company’s stock valued at $96,912,000 after buying an additional 600,000 shares during the period. Institutional investors and hedge funds own 98.05% of the company’s stock.

About Option Care Health

(Get Free Report)

Option Care Health, Inc is a provider of home and alternate-site infusion services in the United States. The company works with patients, physicians, hospitals, health plans and pharmaceutical manufacturers to deliver infusion therapy outside traditional hospital settings, including in patients’ homes, ambulatory infusion centers and other outpatient locations.

Its services include pharmacy and nursing support for intravenous and subcutaneous therapies, care coordination, patient education, clinical monitoring and reimbursement assistance.